BioRestorative Therapies, Inc. Common Stock (NV) Share Price
NASDAQ: BRTXHealthcare
Live BioRestorative Therapies, Inc. Common Stock (NV) Share Price Chart
O H L
BioRestorative Therapies, Inc. Common Stock (NV) Performance Overview
Days Range
▼
$2.61Low
$2.61High
Markets Today
| Previous Close | $2.65 |
|---|---|
| Open | $2.61 |
| Volume | 12,418 |
| Day's Range | $2.61 - $2.61 |
| 52W Range | $2.55 - $34.60 |
| Market Cap | $3.52 M |
Historical Performance
| 1M Returns | -37.68 |
|---|---|
| 3M Returns | -67.59 |
| 6M Returns | -42.01 |
| 1Y Returns | -90.84 |
| 5Y Returns | NA |
| 10Y Returns | NA |
BioRestorative Therapies, Inc. Common Stock (NV) Fundamentals
| Market Cap | $3.52 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $359.70 K |
| ROE TTM | -3.21 |
| EPS TTM | $-21.73 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.07 |
| EBITDA | $-15.44 M |
| Profit Margin | -3959.40 |
| Market Cap | $3.52 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $359.70 K |
| ROE TTM | -3.21 |
| EPS TTM | $-21.73 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.07 |
| EBITDA | $-15.44 M |
| Profit Margin | -3959.40 |
BioRestorative Therapies, Inc. Common Stock (NV) Profit & Loss
Quarterly
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $43.30 K | $25.00 K | $303.30 K | $11.80 K | $19.60 K | $23.17 K |
| Gross Profit + | $39.96 K | $22.09 K | $294.57 K | $1.23 K | $17.96 K | $15.79 K |
| Operating Income | -$2.69 M | -$4.81 M | -$3.31 M | -$3.71 M | -$3.83 M | -$3.39 M |
| EBITDA | -$2.64 M | -$4.76 M | -$3.25 M | -$3.66 M | -$3.77 M | -$3.33 M |
| Interest Expense | $118.99 K | $0 | $73.92 K | $57.74 K | $34.59 K | $0 |
| Depreciation | $50.37 K | $51.78 K | $52.75 K | $52.62 K | $52.84 K | $52.39 K |
| Income Before Tax | -$1.64 M | -$5.34 M | -$2.66 M | -$3.04 M | -$3.21 M | -$2.15 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$1.64 M | -$5.34 M | -$2.66 M | -$3.04 M | -$3.21 M | -$2.15 M |
| Net Profit Margin | -3778.63% | -21359.2% | -875.79% | -25748.11% | -16365.49% | -9298.25% |
BioRestorative Therapies, Inc. Common Stock (NV) Financials Balance Sheet In USD
Quarterly
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $692 | $750 | $797 | $797 | $887 | $2.55 K |
| Reserve & Surplus | -$155.68 M | -$161.02 M | -$163.67 M | -$166.71 M | -$169.92 M | -$172.08 M |
| Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Liabilities | $3.75 M | $4.18 M | $3.67 M | $3.44 M | $3.72 M | $1.61 M |
| Total Liabilities | $3.75 M | $4.18 M | $3.67 M | $3.44 M | $3.72 M | $1.61 M |
| Fixed Assets | $986.88 K | $971.50 K | $918.75 K | $866.13 K | $892.97 K | $840.57 K |
| Current Assets | $11.14 M | $9.36 M | $7.60 M | $4.71 M | $3.14 M | $3.80 M |
| Total Assets | $12.28 M | $10.33 M | $8.52 M | $5.64 M | $4.08 M | $4.64 M |
BioRestorative Therapies, Inc. Common Stock (NV) Cash Flow
Quarterly
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$1.64 M | -$5.34 M | -$2.66 M | -$3.04 M | -$3.21 M | -$2.15 M |
| Operating Cash Flow | -$2.35 M | -$2.78 M | -$2.69 M | -$2.90 M | -$2.42 M | -$3.81 M |
| Investing Cash Flow | $1.53 M | $2.37 M | $2.13 M | $2.00 M | $2.40 M | $968.45 K |
| Financing Cash Flow | -$126.32 K | $1.09 M | $888.14 K | -$49.31 K | $923.24 K | $4.44 M |
| Change in Cash | -$941.55 K | $680.90 K | $326.46 K | -$952.81 K | $908.74 K | $1.60 M |
BioRestorative Therapies, Inc. Common Stock (NV) Return Calculator
The BioRestorative Therapies, Inc. Common Stock (NV) stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About BioRestorative Therapies, Inc. Common Stock (NV)
BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.
Popular Stocks
FAQs
What is the share price of BioRestorative Therapies, Inc. Common Stock (NV) today?
BioRestorative Therapies, Inc. Common Stock (NV) (BRTX) share price as of September 18, 2026 is $2.61. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of BioRestorative Therapies, Inc. Common Stock (NV)?
Yes, Indian Investors can invest in the BioRestorative Therapies, Inc. Common Stock (NV) (BRTX) Share by opening an international trading account with Angel One.
How can I purchase BioRestorative Therapies, Inc. Common Stock (NV) shares in India?
Purchasing BioRestorative Therapies, Inc. Common Stock (NV) (BRTX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying BioRestorative Therapies, Inc. Common Stock (NV) (BRTX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of BioRestorative Therapies, Inc. Common Stock (NV)?
Yes, you can purchase fractional shares of BioRestorative Therapies, Inc. Common Stock (NV) (BRTX) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of BioRestorative Therapies, Inc. Common Stock (NV)?
The market capitalization of BioRestorative Therapies, Inc. Common Stock (NV) on September 18, 2026, is $3.52 M.
In which sector BioRestorative Therapies, Inc. Common Stock (NV) belongs?
BioRestorative Therapies, Inc. Common Stock (NV) operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in BioRestorative Therapies, Inc. Common Stock (NV) stocks?
In order to invest in BioRestorative Therapies, Inc. Common Stock (NV) (BRTX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
